"Receptor, trkC" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A protein-tyrosine kinase receptor that is specific for NEUROTROPHIN 3. It is widely expressed in nervous tissue and may play a role in mediating the effects of NEUROTROPHIN 3 on the proliferation and differentiation of NEURONS.
| Descriptor ID |
D020812
|
| MeSH Number(s) |
D08.811.913.696.620.682.725.400.800 D12.776.543.750.630.499 D12.776.543.750.750.400.550.700
|
| Concept/Terms |
Receptor, trkC- Receptor, trkC
- trkC Receptor
- NTRK3 Receptor
- Receptor, NTRK3
- Receptor, Neurotrophic Tyrosine Kinase Type 3
- NTRK3 Protein
- trkC Protein
- Neurotrophic Tyrosine Kinase Receptor Type 3
- Neurotrophin 3 Receptor
- Receptor, Neurotrophin 3
- Protein-Tyrosine Kinase TRKC
- Kinase TRKC, Protein-Tyrosine
- Protein Tyrosine Kinase TRKC
- TRKC, Protein-Tyrosine Kinase
|
Below are MeSH descriptors whose meaning is more general than "Receptor, trkC".
Below are MeSH descriptors whose meaning is more specific than "Receptor, trkC".
This graph shows the total number of publications written about "Receptor, trkC" by people in this website by year, and whether "Receptor, trkC" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2021 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Receptor, trkC" by people in Profiles.
-
Patient-driven discovery and post-clinical validation of NTRK3 fusion as an acquired resistance mechanism to selpercatinib in RET fusion-positive lung cancer. Ann Oncol. 2021 06; 32(6):817-819.
-
BRCA2, EGFR, and NTRK mutations in mismatch repair-deficient colorectal cancers with MSH2 or MLH1 mutations. Oncotarget. 2017 Jun 20; 8(25):39945-39962.
-
Cytogenetic findings in a case of nodular fasciitis of subclavicular region. Cancer Genet Cytogenet. 2003 Mar; 141(2):160-3.